Home / Resource Library / Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells

Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells

Study examined cardiovascular side effects in patients with lymphoma treated with CAR T therapy.